Medtronic (MDT)
86.97
+0.00 (0.00%)
NYSE · Last Trade: May 20th, 7:19 AM EDT
Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training.
Via Stocktwits · May 19, 2025
Here are three dividend-paying stocks that warrant closer examination.
Via The Motley Fool · May 18, 2025
Why MEDTRONIC PLC (NYSE:MDT) qualifies as a good dividend investing stock.
Via Chartmill · May 10, 2025
Via The Motley Fool · May 8, 2025
Via The Motley Fool · May 6, 2025
Via The Motley Fool · May 3, 2025
Medtronic PLC (NYSE:MDT): A Strong Growth Stock with Technical Breakout Potential
Via Chartmill · May 1, 2025
Via The Motley Fool · April 26, 2025
Cowper Law LLP Defeats Medtronic's Motion for Summary Judgment in MiniMed Insulin Pump Litigation
Via News Direct · April 25, 2025
Via The Motley Fool · April 25, 2025
Medtronic delivers consistent dividend growth and healthcare innovation, positioning it as a stable investment choice in today's dynamic market environment.
Via MarketBeat · April 22, 2025
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.
Via Benzinga · April 18, 2025
The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.
Via Stocktwits · April 17, 2025
U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China.
Via Benzinga · April 16, 2025
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time.
Via Investor's Business Daily · April 10, 2025
Analyzing MEDTRONIC PLC (NYSE:MDT)'s Dividend Potential.
Via Chartmill · April 9, 2025
Via The Motley Fool · April 9, 2025
Via The Motley Fool · March 28, 2025
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.
Via Investor's Business Daily · March 27, 2025